These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23203033)

  • 1. Quantum dots-based immunofluorescent imaging of stromal fibroblasts Caveolin-1 and light chain 3B expression and identification of their clinical significance in human gastric cancer.
    He Y; Zhao X; Gao J; Fan L; Yang G; Cho WC; Chen H
    Int J Mol Sci; 2012 Oct; 13(11):13764-80. PubMed ID: 23203033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caveolin-1 expression level in cancer associated fibroblasts predicts outcome in gastric cancer.
    Zhao X; He Y; Gao J; Fan L; Li Z; Yang G; Chen H
    PLoS One; 2013; 8(3):e59102. PubMed ID: 23527097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment.
    Martinez-Outschoorn UE; Trimmer C; Lin Z; Whitaker-Menezes D; Chiavarina B; Zhou J; Wang C; Pavlides S; Martinez-Cantarin MP; Capozza F; Witkiewicz AK; Flomenberg N; Howell A; Pestell RG; Caro J; Lisanti MP; Sotgia F
    Cell Cycle; 2010 Sep; 9(17):3515-33. PubMed ID: 20855962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr Virus Positive Gastric Cancer: A Distinct Subtype Candidate for Immunotherapy.
    Pereira MA; Batista DAM; Ramos MFKP; Cardili L; Ribeiro RRE; Dias AR; Zilberstein B; Ribeiro U; Cecconello I; Alves VAF; Mello ES
    J Surg Res; 2021 May; 261():130-138. PubMed ID: 33429221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of HER2 and downstream proteins in prediction of advanced tumor phenotypes and overall survival of patients with Epstein-Barr virus-positive vs. negative gastric cancers.
    Zhang YW; He D; Tan C; Dong M; Zhou L; Shao CK
    Pathol Res Pract; 2019 Nov; 215(11):152675. PubMed ID: 31594682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveolin-1 is a modulator of fibroblast activation and a potential biomarker for gastric cancer.
    Shen XJ; Zhang H; Tang GS; Wang XD; Zheng R; Wang Y; Zhu Y; Xue XC; Bi JW
    Int J Biol Sci; 2015; 11(4):370-9. PubMed ID: 25798057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal.
    Ribeiro J; Oliveira A; Malta M; Oliveira C; Silva F; Galaghar A; Afonso LP; Neves MC; Medeiros R; Pimentel-Nunes P; Sousa H
    World J Gastroenterol; 2017 Oct; 23(40):7292-7302. PubMed ID: 29142476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.
    Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y
    Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes.
    Hayashi K; Chen WG; Chen YY; Murakami I; Chen HL; Ohara N; Nose S; Hamaya K; Matsui S; Bacchi MM; Bacchi CE; Chang KL; Weiss LM
    Am J Pathol; 1998 Jan; 152(1):191-8. PubMed ID: 9422536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional analysis of immune genes in Epstein-Barr virus-associated gastric cancer and association with clinical outcomes.
    Sundar R; Qamra A; Tan ALK; Zhang S; Ng CCY; Teh BT; Lee J; Kim KM; Tan P
    Gastric Cancer; 2018 Nov; 21(6):1064-1070. PubMed ID: 29915957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of the Epstein-Barr virus in the normal stomach and gastric lesions in Thai population.
    Wanvimonsuk S; Thitiwanichpiwong P; Keelawat S; Mutirangura A; Kitkumthorn N
    J Med Virol; 2019 Mar; 91(3):444-449. PubMed ID: 30229949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and characteristics of Epstein-Barr virus associated gastric carcinoma in Gansu Province, Northwest China with mRNA expression of glycoprotein BMRF2.
    Guo C; Wei J; Scott RS; Chen Y; Chen Z; Zhao W; Zhang C; Wang B; Chai C; Dai G; Li M; Zhang F
    J Med Virol; 2020 Mar; 92(3):356-363. PubMed ID: 31663617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer.
    Park JH; Kim EK; Kim YH; Kim JH; Bae YS; Lee YC; Cheong JH; Noh SH; Kim H
    Gastric Cancer; 2016 Oct; 19(4):1041-1051. PubMed ID: 26573601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus-associated and Epstein-Barr virus-negative gastric cancer.
    Zhang Y; Chen JN; Dong M; Zhang ZG; Zhang YW; Wu JY; Du H; Li HG; Huang Y; Shao CK
    Hum Pathol; 2017 May; 63():128-138. PubMed ID: 28300576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts.
    Simpkins SA; Hanby AM; Holliday DL; Speirs V
    J Pathol; 2012 Aug; 227(4):490-8. PubMed ID: 22488553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of circulating cell-free Epstein-Barr virus DNA in patients with gastric cancer.
    Shoda K; Ichikawa D; Fujita Y; Masuda K; Hiramoto H; Hamada J; Arita T; Konishi H; Kosuga T; Komatsu S; Shiozaki A; Okamoto K; Imoto I; Otsuji E
    Oncotarget; 2017 Apr; 8(17):28796-28804. PubMed ID: 28430637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P53 deregulation in Epstein-Barr virus-associated gastric cancer.
    Ribeiro J; Malta M; Galaghar A; Silva F; Afonso LP; Medeiros R; Sousa H
    Cancer Lett; 2017 Sep; 404():37-43. PubMed ID: 28729047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes.
    Saeed-Vafa D; Marchion DC; McCarthy SM; Hakam A; Lopez A; Wenham RM; Apte SM; Chen DT; Magliocco AM; Lancaster JM; Reid BM; Permuth JB
    PLoS One; 2021; 16(11):e0256615. PubMed ID: 34813586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of caveolin-1 protein detected by quantum dots technique in human lung cancer invasiveness and metastasis.].
    Chen HL; Zhang YX; Xue JL; Yu BP
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Nov; 32(11):821-4. PubMed ID: 20079291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression.
    Ayala G; Morello M; Frolov A; You S; Li R; Rosati F; Bartolucci G; Danza G; Adam RM; Thompson TC; Lisanti MP; Freeman MR; Vizio DD
    J Pathol; 2013 Sep; 231(1):77-87. PubMed ID: 23729330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.